![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif)
| Tratamiento usado para destruir células T, que desempeña un papel importante en la respuesta inmunitaria. La eliminación de células T de un injerto de médula ósea de un donante puede disminuir las probabilidades de una reacción inmunitaria contra los tejidos del receptor. |
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090511031202im_/http://www.cancer.gov/images/spacer.gif) |